drugset / Trial / NCT00454961

Effectiveness of Artemether-Lumefantrine for Malaria Treatment of Children at Community Level in Tanzania

NCT00454961

Phase 4 Completed 200 enrolled Karolinska University Hospital
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this clinical trial is to assess the effectiveness of artemether-lumefantrine (Coartem®) treatment provided by community health workers against uncomplicated malaria in children under 5 years of age in Kibaha District, Tanzania, during an extended follow-up of 42 days. The hypothesis is that artemether-lumefantrine treatment provided by community health workers will result in less than 85% PCR-corrected parasitological effectiveness by day 42, mainly due to partial non-compliance to full standard 6-dose regimen of the drug.

Timeline

Start
2007-04
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Artemether-lumefantrine Unknown

Indications